Covered recipient · General Payments record
ROSALIE ALCANTARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$683.47
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $401.16 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $246.30 | 13 |
| ABBVIE INC. | $79.14 | 3 |
| Novo Nordisk AS | $46.17 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.51 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422738 | CMS |
| ABBVIE INC. | $25.45 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422740 | CMS |
| ABBVIE INC. | $27.18 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422742 | CMS |
| Amgen Inc. | $32.16 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491446 | CMS |
| Amgen Inc. | $32.11 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491448 | CMS |
| Amgen Inc. | $24.29 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491450 | CMS |
| Amgen Inc. | $34.30 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491452 | CMS |
| Amgen Inc. | $6.31 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491454 | CMS |
| Amgen Inc. | $5.67 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491456 | CMS |
| Amgen Inc. | $7.76 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491460 | CMS |
| Amgen Inc. | $28.97 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491458 | CMS |
| Amgen Inc. | $9.04 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491462 | CMS |
| Amgen Inc. | $10.04 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491464 | CMS |
| Amgen Inc. | $32.71 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491466 | CMS |
| Amgen Inc. | $6.78 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491468 | CMS |
| Amgen Inc. | $16.16 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491470 | CMS |
| Novartis Pharmaceuticals Corporation | $29.55 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086716961 | CMS |
| Novo Nordisk Inc | $19.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100420693 | CMS |
| Novo Nordisk Inc | $26.56 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.